NEW YORK (GenomeWeb News) – Luminex today said that it has signed an agreement with Mingyuan Medicare Development Company for distribution of its genetic tests in China and Hong Kong.
 
Mingyuan will exclusively distribute a series of newborn screening products based on Luminex’s xMAP technology, which the Austin, Texas-based firm said enables simultaneous analysis of up to 100 assays within a single sample. Mingyuan also will distribute Luminex’s analyzers in China and Hong Kong.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.